Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer

Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer

Abstract Background In the current treatment of non-small cell lung cancer (NSCLC), traditional chemotherapy causes high toxicity, so it is necessary to develop safe chemical drug delivery vehicles clinically. Chemotherapy monotherapy is prone to drug resistance. Chemotherapy combined with other the...

Full description

Bibliographic Details
Main Authors: Tiantian Tan, Yuxin Feng, Weimin Wang, Rongrong Wang, Liyan Yin, Yiying Zeng, Zhaowu Zeng, Tian Xie
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Cancer Nanotechnology
Subjects:
Cabazitaxel
Albumin
Paclitaxel-resistant NSCLC
Lipid nanoparticles
TGFβ-1 siRNA
Online Access:https://doi.org/10.1186/s12645-023-00194-7

Internet

https://doi.org/10.1186/s12645-023-00194-7

Similar Items